• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 Methylphenidate Hydrochloride ER Capsules/Tablets

 Status: Resolved

 » Duration of Shortage: 02/19/2013 - 08/05/2014
 » Therapeutic Categories: Pediatric; Psychiatry

Actavis, Inc. (Revised 08/05/2014)

Company Contact Information:
800-272-5525

Presentation
  • Methylphenidate Hydrochloride, ER Capsules, 20 mg, 100s (NDC 67767-0200-01)
  • Methylphenidate Hydrochloride, ER Capsules, 30 mg, 100s (NDC 67767-0201-01)
  • Methylphenidate Hydrochloride, ER Capsules, 40 mg, 100s (NDC 67767-0202-01)
  • Methylphenidate Hydrochloride, ER Tablets, 18 MG 100s (NDC 00591-2715-01)
  • Methylphenidate Hydrochloride, ER Tablets, 27 MG 100s (NDC 00591-2716-01)
  • Methylphenidate Hydrochloride, ER Tablets, 36 MG 100s (NDC 00591-2717-01)
  • Methylphenidate Hydrochloride, ER Tablets, 54 MG 100s (NDC 00591-2718-01)
Note:
  • No supply issues anticipated.

Mallinckrodt (Revised 08/05/2014)

Company Contact Information:
800-325-8888

Presentation
  • 10 mg ER tablets 100 package size (NDC 00406-1445-01)
  • 20 mg ER tablets 100 package size (NDC 00406-1473-01)
Note:
  • No supply issues anticipated.

Sandoz (Revised 08/05/2014)

Company Contact Information:
609-627-8500

Presentation
  • 20 mg Sustained-Release, 100s (NDC 00781-5754-01)
Note:
  • No supply issues anticipated.

Teva Pharmaceuticals (Revised 08/05/2014)

Company Contact Information:
800-545-8800

Presentation
  • 20mg, 100 count (NDC 0093-5346-01)
  • 30mg, 100 count (NDC 0093-5347-01)
  • 40mg, 100 count (NDC 0093-5348-01)
Note:
  • No supply issues anticipated.

UCB Inc. (Revised 08/05/2014)

Company Contact Information:
800-477-7877

Presentation
  • 20 mg Methylphenidate ER, 100s (NDC 53014-594-07)
Note:
  • No supply issues anticipated.
-
-